MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹9,925 Cr | ₹801,705 Cr | ₹6,737 Cr | ₹533 Cr | ₹44,380 Cr |
What is the latest Appropriations of MANKIND PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹9,925 Cr |
| Mar2024 | ₹801,705 Cr |
| Mar2023 | ₹6,737 Cr |
| Mar2022 | ₹533 Cr |
| Mar2021 | ₹44,380 Cr |
How is Appropriations of MANKIND PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,925 Cr | -98.76 | |
| Mar2024 | ₹801,705 Cr | 11,800.05 | |
| Mar2023 | ₹6,737 Cr | 1,163.76 | |
| Mar2022 | ₹533 Cr | -98.80 | |
| Mar2021 | ₹44,380 Cr | - | |
Compare Appropriations of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹90,068.8 Cr | -0.3% | -3% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.3% |
-3% |
-24.7% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses